SE0002202D0 - New peptides - Google Patents

New peptides

Info

Publication number
SE0002202D0
SE0002202D0 SE0002202A SE0002202A SE0002202D0 SE 0002202 D0 SE0002202 D0 SE 0002202D0 SE 0002202 A SE0002202 A SE 0002202A SE 0002202 A SE0002202 A SE 0002202A SE 0002202 D0 SE0002202 D0 SE 0002202D0
Authority
SE
Sweden
Prior art keywords
new peptides
alkylating
invention refers
peptides
new
Prior art date
Application number
SE0002202A
Other languages
English (en)
Swedish (sv)
Inventor
Rolf Lewensohn
Joakim Gullbo
Rolf Larsson
Hans Ehrsson
Kristina Luthman
Original Assignee
Karolinska Innovations Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Karolinska Innovations Ab filed Critical Karolinska Innovations Ab
Priority to SE0002202A priority Critical patent/SE0002202D0/xx
Publication of SE0002202D0 publication Critical patent/SE0002202D0/xx
Priority to PCT/SE2001/001318 priority patent/WO2001096367A1/en
Priority to US10/297,588 priority patent/US6992207B2/en
Priority to ES01938945T priority patent/ES2341702T3/es
Priority to CA2408501A priority patent/CA2408501C/en
Priority to AU2001264515A priority patent/AU2001264515A1/en
Priority to EP01938945A priority patent/EP1290011B1/en
Priority to JP2002510508A priority patent/JP4798930B2/ja
Priority to DE60141398T priority patent/DE60141398D1/de
Priority to DK01938945.1T priority patent/DK1290011T3/da
Priority to PT01938945T priority patent/PT1290011E/pt
Priority to AT01938945T priority patent/ATE458746T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06191—Dipeptides containing heteroatoms different from O, S, or N
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0827—Tripeptides containing heteroatoms different from O, S, or N
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
SE0002202A 2000-06-13 2000-06-13 New peptides SE0002202D0 (sv)

Priority Applications (12)

Application Number Priority Date Filing Date Title
SE0002202A SE0002202D0 (sv) 2000-06-13 2000-06-13 New peptides
AT01938945T ATE458746T1 (de) 2000-06-13 2001-06-11 Melphalan-derivate und ihre verwendung als chemotherapeutika gegen krebs
CA2408501A CA2408501C (en) 2000-06-13 2001-06-11 Melphalan derivatives and their use as cancer chemotherapeutic drugs
US10/297,588 US6992207B2 (en) 2000-06-13 2001-06-11 Melphalan derivatives and their use as cancer chemotherapeutic drugs
ES01938945T ES2341702T3 (es) 2000-06-13 2001-06-11 Derivados de melfalan y su uso como farmacos quimioterapeuticos del cancer.
PCT/SE2001/001318 WO2001096367A1 (en) 2000-06-13 2001-06-11 Melphalan derivatives and their use as cancer chemotherapeutic drugs
AU2001264515A AU2001264515A1 (en) 2000-06-13 2001-06-11 Melphalan derivatives and their use as cancer chemotherapeutic drugs
EP01938945A EP1290011B1 (en) 2000-06-13 2001-06-11 Melphalan derivatives and their use as cancer chemotherapeutic drugs
JP2002510508A JP4798930B2 (ja) 2000-06-13 2001-06-11 メルファラン誘導体及び癌の化学療法薬としてのその使用
DE60141398T DE60141398D1 (de) 2000-06-13 2001-06-11 Melphalan-derivate und ihre verwendung als chemotherapeutika gegen krebs
DK01938945.1T DK1290011T3 (da) 2000-06-13 2001-06-11 Melphalan-derivater og deres anvendelse som cancer-kemoterapeutiske lægemidler
PT01938945T PT1290011E (pt) 2000-06-13 2001-06-11 Derivados de melfalano e seu uso como drogas quimioterapêuticas de cancro

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE0002202A SE0002202D0 (sv) 2000-06-13 2000-06-13 New peptides

Publications (1)

Publication Number Publication Date
SE0002202D0 true SE0002202D0 (sv) 2000-06-13

Family

ID=20280067

Family Applications (1)

Application Number Title Priority Date Filing Date
SE0002202A SE0002202D0 (sv) 2000-06-13 2000-06-13 New peptides

Country Status (10)

Country Link
EP (1) EP1290011B1 (enExample)
JP (1) JP4798930B2 (enExample)
AT (1) ATE458746T1 (enExample)
AU (1) AU2001264515A1 (enExample)
CA (1) CA2408501C (enExample)
DK (1) DK1290011T3 (enExample)
ES (1) ES2341702T3 (enExample)
PT (1) PT1290011E (enExample)
SE (1) SE0002202D0 (enExample)
WO (1) WO2001096367A1 (enExample)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1374907A3 (en) * 2002-06-24 2004-01-07 Ghanem Elias c/o Institut Jules Bordet Ghanem Drug transport and delivery system
DE10239832A1 (de) * 2002-08-29 2004-03-18 Lipal Biochemicals AG c/o University of Zurich Sarcolysyl-Derivate und Verfahren zu deren Herstellung
WO2011011865A1 (en) * 2009-07-29 2011-02-03 3R Valo, S.E.C. Anticancer agents based on amino acid derivatives
WO2011078782A1 (en) * 2009-12-22 2011-06-30 Oncopeptides Ab A composition comprising of melphalan derivatives and gemcitabine or etoposide useful in the treatment of cancer
HUE037863T2 (hu) 2011-04-28 2018-09-28 Oncopeptides Ab Citotoxikus dipeptidek liofilizált készítménye
PT3228319T (pt) * 2011-04-28 2020-08-27 Oncopeptides Ab Preparação liofilizada de dipéptidos citotóxicos
RS60068B1 (sr) * 2012-10-26 2020-05-29 Oncopeptides Ab Liofilisani preparati melfalan flufenamida
DK2928463T3 (da) * 2012-10-26 2020-02-24 Oncopeptides Ab Lyofiliserede præparater af melphalan-flufenamid
GB201507903D0 (en) 2015-05-08 2015-06-24 Oncopeptides Ab Process for preparation of nitrogen mustard derivatives
GB201521217D0 (en) 2015-12-01 2016-01-13 Oncopeptides Ab Dosage regimens
CN108864251B (zh) * 2018-06-30 2022-06-14 大连理工大学 一类氨肽酶n激活的药物前体化合物及其制备方法和应用
HUE061801T2 (hu) 2018-10-18 2023-08-28 Oncopeptides Ab Deutérium-tartalmú vegyületek
US12396975B2 (en) 2019-04-03 2025-08-26 Oncopeptides Ab Treatment of al amyloidosis with melflufen
GB201905477D0 (en) * 2019-04-17 2019-05-29 Oncopeptides Ab Novel formulations
WO2021053185A1 (en) 2019-09-20 2021-03-25 Oncopeptides Ab Melflufen formulations and their use in the treatment or prophylaxis of osteosarcoma
WO2022167087A1 (en) * 2021-02-05 2022-08-11 Oncopeptides Ab Peptidase enhanced cytotoxic dipeptides
EP4083052A1 (en) 2021-04-29 2022-11-02 BKmdcl AB Peptide conjugates of melphalan for the treatment of cancer
EP4347615B1 (en) 2021-06-01 2025-05-21 Synthon B.V. Process for making melflufen or a salt thereof
GB202109896D0 (en) 2021-07-08 2021-08-25 Oncopeptides Ab Novel treatments
GB202109894D0 (en) 2021-07-08 2021-08-25 Oncopeptides Ab Novel treatments
GB202109895D0 (en) 2021-07-08 2021-08-25 Oncopeptides Ab Novel treatments
EP4366721A1 (en) 2021-07-08 2024-05-15 Oncopeptides Innovation AB Melflufen for use in the treatment of multiple myeloma
GB202204171D0 (en) 2022-03-24 2022-05-11 Oncopeptides Ab Novel formulations

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB750155A (en) 1953-03-17 1956-06-13 Nat Res Dev Substituted alanines

Also Published As

Publication number Publication date
AU2001264515A1 (en) 2001-12-24
CA2408501A1 (en) 2001-12-20
CA2408501C (en) 2011-01-18
JP4798930B2 (ja) 2011-10-19
DK1290011T3 (da) 2010-06-07
EP1290011B1 (en) 2010-02-24
JP2004503564A (ja) 2004-02-05
WO2001096367A1 (en) 2001-12-20
EP1290011A1 (en) 2003-03-12
ES2341702T3 (es) 2010-06-25
PT1290011E (pt) 2010-05-11
ATE458746T1 (de) 2010-03-15

Similar Documents

Publication Publication Date Title
SE0002202D0 (sv) New peptides
BR9713404A (pt) ésteres de n-(aril/heteroarilacetil) aminoácidos, composições farmacêuticas compreendendo os mesmos, e métodos para a inibição da liberação de peptìdeo beta-amilóide e/ou de sua sìntese por uso de tais compostos.
DK1178958T3 (da) N-cyanomethylamider som proteaseinhibitorer
DZ3197A1 (fr) Acides aminés bicycliques utilises comme agents pharmaceutiques.
NZ593815A (en) Tissue factor pathway inhibitor (tfpi) inhibitors and methods of use
BR9714358A (pt) Derivados de n- (arila/heteroarila) amino ácido,composições farmacêuticas compreendendo os mesmos, e métodos para a inibição de liberação de peptìdeo beta-amilóide e/ou sua sìntese por uso de tais compostos
WO2004091497A3 (en) Methods and compositions for increasing the anaerobic working capacity in tissues
DE602004017871D1 (de) Zubereitungen zur behandlung von arthritischen erscheinungen
BR0009472A (pt) Antagonistas de lhrh com propriedades desolubilidade aperfeiçoadas
WO2001068645A3 (en) N-cyanomethylcarboxamides and their use as protease inhibitors
ES2422081T3 (es) Péptido Ser-Ser-Ser-Arg y sus utilizaciones medicinales
ATE516027T1 (de) Orazamid orotat zur vorbeugung von leberschäden
WO2002062304A3 (de) Kosmetische und/oder pharmazeutische mittel acylierte aminosäure und proteinkondensat enthaltend.
NO955067D0 (no) FVII/TF peptider
WO2005002500A3 (en) Inhibitors of coronavirus
EE200300213A (et) SARP-1 kasutamine sklerodermia raviks ja/või ennetamiseks
BR0109279A (pt) Antagonistas de lhrh, sua preparação e aplicação como medicamento
ATE371737T1 (de) Proteaseresistente flint-analoge
BR9811954A (pt) ácidos 3-aril-succinamido-hidroxâmicos, processos para sua produção e preparações farmacêuticas contendo estas substâncias
IT1318556B1 (it) Composizione farmaceutica a base di prolina, glicina e lisina utilenella terapia per la cicatrizzazione delle ferite e delle lesioni
MXPA02001268A (es) Antagonistas de il-16.
FI942938L (fi) Soijaproteiini tai -hydrolysaatit farmaseuttisissa koostumuksissa bioaktiivisten peptidien suojana entsymaattista inaktivoitumista vastaan
WO2003025014A3 (fr) Utilisation de peptides comportant des modifications de type post-traductionnel dans le cadre du traitement de pathologies auto-immunes
DE60015559D1 (de) Sentrin-spezifische menschliche protease senp1
DE60137340D1 (de) Inhibitoren von hiv-replikation und verfahren zur behandlung einer der von hiv verursachten infektionen